With A Regionalized Approach, Sanofi Launches Allstar To Widen Its India Insulin Portfolio
This article was originally published in PharmAsia News
Executive Summary
The French drug maker hopes for quicker insulin initiation as part of its efforts to grow in a sector dominated by Novo Nordisk.